Myles Greenberg

April 4, 2024

Dr. Myles Greenberg has more than 25 years of experience in growing healthcare, medical technology and life sciences firms as an entrepreneur, operating executive, board member, clinician and investor. Myles currently serves as President and Chief Executive Officer of Alucent Biomedical, Inc. Alucent is developing a novel drug-device combination therapy for the treatment of patients with vascular disease. President & Chief Executive Officer, Alucent Biomedical, Inc. Prior to joining Alucent as CEO, he served as chief development officer at IntegraMed America (now part of US Fertility), a private equity backed healthcare services firm. Previously, Myles was a partner or principal at early-stage venture capital firms CHL Medical Partners, HealthInvest Equity Partners and Pappas Ventures. As a start-up venture investor and board member, he often served as lead director or in an interim executive management role at many dynamic companies in the biotechnology, medical device, and healthcare services and information technology sectors, such as Ambra Health (acquired by Intelerad Medical Systems), Angiomics (acquired by PDL BioPharma), Flowcardia (acquired by CR Bard), Liposcience (acquired by LabCorp), Millennium Pharmacy Systems (acquired by PharMerica), Oriel Therapeutics (acquired by Novartis / Sandoz), NuVasive (Nasdaq: NUVA), Syntonix Pharmaceuticals (acquired by Biogen Idec), Urgent Care Centers of New England / CareWell Urgent Care (acquired by a private equity firm), and Vascular Pathways (acquired by CR Bard). In addition to leading the Alucent team, Myles currently serves as vice chair of the board of directors of BioUtah, Utah’s life sciences trade association, and Focused Therapeutics, a start-up medical device company that he co-founded. He also serves the University of Utah as an adjunct faculty member & Entrepreneur-In-Residence for the Center for Medical Innovation at the School of Medicine. Myles began his career as a faculty physician and asst clinical director at Beth Israel Deaconess Medical Center / Harvard Medical School in Boston. He holds an MBA from Harvard Business School, MD from the Yale University School of Medicine and a BAS from the University of Pennsylvania School of Engineering and Applied Science and is a Diplomate of the American Board of Emergency Medicine.